{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:44:38Z","timestamp":1792190678996,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"crossref","award":["3D43TW010540-05-S3"],"award-info":[{"award-number":["3D43TW010540-05-S3"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"crossref","award":["K43TW011416"],"award-info":[{"award-number":["K43TW011416"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10552-023-01764-1","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T08:02:06Z","timestamp":1690963326000},"page":"9-20","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utilization of opportunistic cervical cancer screening in Nigeria"],"prefix":"10.1007","volume":"35","author":[{"given":"Magdiel A.","family":"Habila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Sagay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mavis","family":"Obeng-Kusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam J.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Magaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iornum H.","family":"Shambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Daru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purnima","family":"Madhivanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atiene S.","family":"Sagay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"issue":"2","key":"1764_CR1","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/s2214-109x(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V et al (2023) Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health 11(2):e197\u2013e206. https:\/\/doi.org\/10.1016\/s2214-109x(22)00501-0","journal-title":"Lancet Glob Health"},{"key":"1764_CR2","unstructured":"National Cancer Institute (2022) SEER cancer stat facts: cervical cancer. National Cancer Institute, Bethesda. https:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html"},{"key":"1764_CR3","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3332\/ecancer.2019.948","volume":"13","author":"MP Curado","year":"2019","unstructured":"Curado MP (2019) Importance of hospital cancer registries in Africa. Ecancermedicalscience 13:948\u2013948. https:\/\/doi.org\/10.3332\/ecancer.2019.948","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"1764_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41416-020-0831-9","volume":"123","author":"E Jedy-Agba","year":"2020","unstructured":"Jedy-Agba E, Joko WY, Liu B et al (2020) Trends in cervical cancer incidence in sub-Saharan Africa. Br J Cancer 123(1):148\u2013154. https:\/\/doi.org\/10.1038\/s41416-020-0831-9","journal-title":"Br J Cancer"},{"key":"1764_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31393-9","author":"O Ginsburg","year":"2017","unstructured":"Ginsburg O, Badwe R, Boyle P et al (2017) Changing global policy to deliver safe, equitable, and affordable care for women\u2019s cancers. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(16)31393-9","journal-title":"Lancet"},{"issue":"2","key":"1764_CR6","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/s1470-2045(18)30019-6","volume":"19","author":"A Znaor","year":"2018","unstructured":"Znaor A, Eser S, Anton-Culver H et al (2018) Cancer surveillance in northern Africa, and central and western Asia: challenges and strategies in support of developing cancer registries. Lancet Oncol 19(2):e85\u2013e92. https:\/\/doi.org\/10.1016\/s1470-2045(18)30019-6","journal-title":"Lancet Oncol"},{"key":"1764_CR7","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L et al (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8:e191\u2013e203. https:\/\/doi.org\/10.1016\/S2214-109X(19)30482-6","journal-title":"Lancet Glob Health"},{"issue":"2","key":"1764_CR8","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/s2214-109x(20)30459-9","volume":"9","author":"D Stelzle","year":"2021","unstructured":"Stelzle D, Tanaka LF, Lee KK et al (2021) Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health 9(2):e161\u2013e169. https:\/\/doi.org\/10.1016\/s2214-109x(20)30459-9","journal-title":"Lancet Glob Health"},{"key":"1764_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1186\/s12913-018-3700-y","volume":"18","author":"J Musa","year":"2018","unstructured":"Musa J, Achenbach CJ, Evans CT et al (2018) Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical cancer screening setting in Jos, Nigeria. BMC Health Serv Res 18:885. https:\/\/doi.org\/10.1186\/s12913-018-3700-y","journal-title":"BMC Health Serv Res"},{"issue":"Suppl 1","key":"1764_CR10","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jcv.2013.07.002","volume":"58","author":"S Masciotra","year":"2013","unstructured":"Masciotra S, Luo W, Youngpairoj AS et al (2013) Performance of the Alere Determine\u2122 HIV-1\/2 Ag\/Ab combo rapid test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast. J Clin Virol 58(Suppl 1):e54\u2013e58. https:\/\/doi.org\/10.1016\/j.jcv.2013.07.002","journal-title":"J Clin Virol"},{"issue":"4","key":"1764_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.29063\/ajrh2017\/v21i4.2","volume":"21","author":"J Musa","year":"2017","unstructured":"Musa J (2017) The need for societal investment to improve cervical cancer outcomes in Nigeria: a commentary. Afr J Reprod Health 21(4):17\u201323. https:\/\/doi.org\/10.29063\/ajrh2017\/v21i4.2","journal-title":"Afr J Reprod Health"},{"issue":"16","key":"1764_CR12","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D, Davey D, Kurman R et al (2002) The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287(16):2114\u20132119. https:\/\/doi.org\/10.1001\/jama.287.16.2114","journal-title":"JAMA"},{"issue":"1","key":"1764_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ajog.2004.01.043","volume":"191","author":"RP Insinga","year":"2004","unstructured":"Insinga RP, Glass AG, Rush BB (2004) Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol 191(1):105\u2013113. https:\/\/doi.org\/10.1016\/j.ajog.2004.01.043","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1764_CR14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0029-7844(98)00080-5","volume":"91","author":"WK Kinney","year":"1998","unstructured":"Kinney WK, Manos MM, Hurley LB, Ransley JE (1998) Where\u2019s the high-grade cervical neoplasia? The importance of minimally abnormal papanicolaou diagnoses. Obstet Gynecol 91(6):973\u2013976. https:\/\/doi.org\/10.1016\/S0029-7844(98)00080-5","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1764_CR15","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1038\/s41598-020-59944-x","volume":"10","author":"J Nazziwa","year":"2020","unstructured":"Nazziwa J, Faria NR, Chaplin B et al (2020) Characterisation of HIV-1 molecular epidemiology in Nigeria: origin, diversity, demography and geographic spread. Sci Rep 10(1):3468. https:\/\/doi.org\/10.1038\/s41598-020-59944-x","journal-title":"Sci Rep"},{"issue":"4","key":"1764_CR16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.sjbs.2016.03.006","volume":"25","author":"AA Awofala","year":"2018","unstructured":"Awofala AA, Ogundele OE (2018) HIV epidemiology in Nigeria. Saudi J Biol Sci 25(4):697\u2013703. https:\/\/doi.org\/10.1016\/j.sjbs.2016.03.006","journal-title":"Saudi J Biol Sci"},{"key":"1764_CR17","volume-title":"Nigeria HIV\/AIDS indicator and impact survey (NAIIS) 2018: technical report","author":"Federal Ministry of Health, Nigeria","year":"2019","unstructured":"Federal Ministry of Health, Nigeria (2019) Nigeria HIV\/AIDS indicator and impact survey (NAIIS) 2018: technical report. Federal Ministry of Health, Nigeria, Abuja"},{"issue":"1","key":"1764_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1186\/s12913-018-3700-y","volume":"18","author":"J Musa","year":"2018","unstructured":"Musa J, Achenbach CJ, Evans CT et al (2018) Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical cancer screening setting in Jos, Nigeria. BMC Health Serv Res 18(1):885. https:\/\/doi.org\/10.1186\/s12913-018-3700-y","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"1764_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/2325957413488191","volume":"14","author":"CC Dim","year":"2015","unstructured":"Dim CC, Onyedum CC, Dim NR, Chukwuka JC (2015) Cervical cancer screening among HIV-positive women in Nigeria: an assessment of use and willingness to pay in the absence of donor support. J Int Assoc Provid AIDS Care 14(3):241\u2013244. https:\/\/doi.org\/10.1177\/2325957413488191","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"1764_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2458-13-46","volume":"13","author":"OC Ezechi","year":"2013","unstructured":"Ezechi OC, Gab-Okafor CV, Ostergren PO, Odberg PK (2013) Willingness and acceptability of cervical cancer screening among HIV positive Nigerian women. BMC Public Health 13:46. https:\/\/doi.org\/10.1186\/1471-2458-13-46","journal-title":"BMC Public Health"},{"issue":"6","key":"1764_CR21","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s13187-017-1229-0","volume":"33","author":"MO Adibe","year":"2018","unstructured":"Adibe MO, Aluh DO (2018) Awareness, knowledge and attitudes towards cervical cancer amongst HIV-positive women receiving care in a tertiary hospital in Nigeria. J Cancer Educ 33(6):1189\u20131194. https:\/\/doi.org\/10.1007\/s13187-017-1229-0","journal-title":"J Cancer Educ"},{"issue":"3","key":"1764_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4103\/0300-1652.114590","volume":"54","author":"S Odafe","year":"2013","unstructured":"Odafe S, Torpey K, Khamofu H et al (2013) Integrating cervical cancer screening with HIV care in a district hospital in Abuja, Nigeria. Niger Med J 54(3):176\u2013184. https:\/\/doi.org\/10.4103\/0300-1652.114590","journal-title":"Niger Med J"},{"key":"1764_CR23","doi-asserted-by":"publisher","first-page":"697607","DOI":"10.3389\/fgwh.2021.697607","volume":"2","author":"MA Habila","year":"2021","unstructured":"Habila MA, Kimaru LJ, Mantina N et al (2021) Community-engaged approaches to cervical cancer prevention and control in sub-Saharan Africa: a scoping review. Front Glob Womens Health 2:697607. https:\/\/doi.org\/10.3389\/fgwh.2021.697607","journal-title":"Front Glob Womens Health"},{"issue":"5","key":"1764_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.21628","volume":"70","author":"ETH Fontham","year":"2020","unstructured":"Fontham ETH, Wolf AMD, Church TR et al (2020) Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin 70(5):321\u2013346. https:\/\/doi.org\/10.3322\/caac.21628","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1764_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4103\/tjog.Tjog_88_18","volume":"35","author":"O Akinola","year":"2018","unstructured":"Akinola O, Aimakhu C, Ezechi O, Fasubaa O (2018) Society of obstetrics and gynecology of Nigeria\u2014clinical practice guidelines: guidelines for the prevention of cervical cancer. Editorial review. Trop J Obstet Gynaecol 35(3):371\u2013376. https:\/\/doi.org\/10.4103\/tjog.Tjog_88_18","journal-title":"Trop J Obstet Gynaecol"},{"issue":"1","key":"1764_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1186\/1471-2458-14-656","volume":"14","author":"SN Akarolo-Anthony","year":"2014","unstructured":"Akarolo-Anthony SN, Famooto AO, Dareng EO et al (2014) Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC Public Health 14(1):656. https:\/\/doi.org\/10.1186\/1471-2458-14-656","journal-title":"BMC Public Health"},{"key":"1764_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1743-422x-11-5","volume":"11","author":"OC Ezechi","year":"2014","unstructured":"Ezechi OC, Ostergren PO, Nwaokorie FO, Ujah IA, Odberg PK (2014) The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women. Virol J 11:5. https:\/\/doi.org\/10.1186\/1743-422x-11-5","journal-title":"Virol J"},{"issue":"2","key":"1764_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.soncn.2019.02.003","volume":"35","author":"CA Johnson","year":"2019","unstructured":"Johnson CA, James D, Marzan A, Armaos M (2019) Cervical cancer: an overview of pathophysiology and management. Semin Oncol Nurs 35(2):166\u2013174. https:\/\/doi.org\/10.1016\/j.soncn.2019.02.003","journal-title":"Semin Oncol Nurs"},{"issue":"1","key":"1764_CR29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0300-1652.80070","volume":"52","author":"AM Abasiattai","year":"2011","unstructured":"Abasiattai AM, Utuk MN, Ojeh SO, Eyo UE (2011) Combined oral contraceptive pills: profile of acceptors in a tertiary hospital in South-South Nigeria. Niger Med J 52(1):19\u201323","journal-title":"Niger Med J"},{"key":"1764_CR30","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2147\/ppa.S72952","volume":"9","author":"JO Egede","year":"2015","unstructured":"Egede JO, Onoh RC, Umeora OU, Iyoke CA, Dimejesi IB, Lawani LO (2015) Contraceptive prevalence and preference in a cohort of south-east Nigerian women. Patient Prefer Adherence 9:707\u2013714. https:\/\/doi.org\/10.2147\/ppa.S72952","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"1764_CR31","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12888-022-04210-9","volume":"22","author":"IA Adeoye","year":"2022","unstructured":"Adeoye IA (2022) Alcohol consumption and tobacco exposure among pregnant women in Ibadan, Nigeria. BMC Psychiatry 22(1):570. https:\/\/doi.org\/10.1186\/s12888-022-04210-9","journal-title":"BMC Psychiatry"},{"issue":"8","key":"1764_CR32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.trstmh.2009.03.020","volume":"103","author":"CC Dim","year":"2009","unstructured":"Dim CC, Ekwe E, Madubuko T, Dim NR, Ezegwui HU (2009) Improved awareness of pap smear may not affect its use in Nigeria: a case study of female medical practitioners in Enugu, southeastern Nigeria. Trans R Soc Trop Med Hyg 103(8):852\u2013854. https:\/\/doi.org\/10.1016\/j.trstmh.2009.03.020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1764_CR33","first-page":"69","volume":"11","author":"OS Arulogun","year":"2012","unstructured":"Arulogun OS, Maxwell OO (2012) Perception and utilization of cervical cancer screening services among female nurses in University College Hospital, Ibadan, Nigeria. Pan Afr Med J 11:69","journal-title":"Pan Afr Med J"},{"issue":"2","key":"1764_CR34","doi-asserted-by":"publisher","first-page":"484","DOI":"10.4081\/jphia.2015.484","volume":"6","author":"H Nwobodo","year":"2015","unstructured":"Nwobodo H, Ba-Break M (2015) Analysis of the determinants of low cervical cancer screening uptake among Nigerian women. J Public Health Afr 6(2):484. https:\/\/doi.org\/10.4081\/jphia.2015.484","journal-title":"J Public Health Afr"},{"key":"1764_CR35","doi-asserted-by":"publisher","first-page":"100392","DOI":"10.1016\/j.ctarc.2021.100392","volume":"28","author":"UW Dozie","year":"2021","unstructured":"Dozie UW, Elebari BL, Nwaokoro CJ et al (2021) Knowledge, attitude and perception on cervical cancer screening among women attending ante-natal clinic in Owerri west L.G.A, South-Eastern Nigeria: a cross-sectional study. Cancer Treat Res Commun 28:100392. https:\/\/doi.org\/10.1016\/j.ctarc.2021.100392","journal-title":"Cancer Treat Res Commun"},{"key":"1764_CR36","volume-title":"A global strategy towards the elimination of cervical cancer as a public health problem","author":"World Health Organization","year":"2019","unstructured":"World Health Organization (2019) A global strategy towards the elimination of cervical cancer as a public health problem. World Health Organization, Geneva"},{"issue":"4","key":"1764_CR37","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/ijgc-2020-001285","volume":"30","author":"M Gultekin","year":"2020","unstructured":"Gultekin M, Ramirez PT, Broutet N, Hutubessy R (2020) World Health Organization call for action to eliminate cervical cancer globally. Int J Gynecol Cancer 30(4):426. https:\/\/doi.org\/10.1136\/ijgc-2020-001285","journal-title":"Int J Gynecol Cancer"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01764-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-023-01764-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01764-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T14:36:58Z","timestamp":1729867018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-023-01764-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1764"],"URL":"https:\/\/doi.org\/10.1007\/s10552-023-01764-1","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This project was reviewed and approved by the Institutional Review Board Human Subjects Protection Program at the University of Arizona (Protocol Number: 2108135158) and by the Institutional Review Board at Jos University (Reference: JUTH\/DCS\/IREC\/127\/XXI\/2575). All methods described were performed in accordance with the Declaration of Helsinki and with the relevant guidelines and regulations outlined by the Human Subjects Protection Program at the University of Arizona and by the IRB at Jos University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The IRB at the University of Arizona waived the need to obtain informed consent from participants since these analyses were conducted using de-identified data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}